'Pharma Bro' Shkreli Won't Stop Talking, Except To Jury In Trial"Pharma Bro" Martin Shkreli has kept up his trademark trolling on social media during his securities fraud trial — calling the case "bogus" — but the jury won't hear him defend himself in court.
Martin Shkreli Allegedly Spent $10K On JAY-Z Tickets With Company FundsRecords indicate that Retrophin funded his expensive concert venture when the organization was already on a tight budget.
Right-Wing Yiannopoulos Crashes UC Davis After Protest Shuts Down SpeechYiannopoulos stood on a picnic table Saturday at the campus quad and used a megaphone to decry the cancellation of his speech.
Protests Shut Down Far-Right Speaker At UC DavisSpeeches by far-right commentator Milo Yiannopoulos and former pharmaceutical executive Martin Shkreli were canceled after heated protests erupted at UC Davis.
Twitter Boots Ex-Pharma Exec Martin Shkreli For HarassmentFormer pharmaceutical executive Martin Shkreli has been suspended from San Francisco-based Twitter for harassing a journalist.
Florida Woman Wins Chance To Punch Martin Shkreli In The FaceA woman from Florida has won the chance to punch embattled pharmaceutical executive Martin Shkreli in the face.
Martin Shkreli Auctions Off Chance To Punch Him In The FaceEmbattled pharmaceutical executive Martin Shkreli is giving some people what they want - a chance to punch him in the face.
Martin Shkreli Pleads Not Guilty To New Charges In Securities Fraud CaseA pharmaceutical executive who came under fire for jacking up the price of a lifesaving malaria medication has pleaded not guilty to new charges in his securities fraud case.
‘Most Hated’ CEO Shkreli Used $45 Million E-Trade Account To Secure BailMartin Shkreli, who has been dubbed as the “most hated CEO in America,” is reportedly worth at least $45 million.
San Francisco-Based Kalobios Files For BankruptcyKalobios, the troubled South San Francisco-based drugmaker taken over by Martin Shkreli last month, is seeking bankruptcy protection less than two weeks after his arrest on securities fraud.
Nasdaq To Delist Company Run By Drug Price-Gouger ShkreliOne of the biotech companies run by Martin Shkreli, the drug price-gouger charged with securities fraud last week, has been told that its stock will be delisted by Nasdaq because of Shkreli's arrest and other factors.